Jinyu Bio-Technology Co (SHSE:600201) Ending Cash Position: ¥597 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600201 Jinyu Bio-Technology Co Ltd SHSE:600201
60 GF Score
Price ¥12.30
GF Value ¥9.13
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Jinyu Bio-Technology Co Ending Cash Position?

Jinyu Bio-Technology Co SHSE:600201 -0.16% 60 Ending Cash Position is ¥597 Mil as of Jun. 2026. GuruFocus rates SHSE:600201 with a GF Score™ of 60/100 and a GF Value™ of ¥9.13 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Jinyu Bio-Technology Co's Ending Cash Position for the quarter that ended in Jun. 2026 was ¥597 Mil.

Jinyu Bio-Technology Co's quarterly Ending Cash Position declined from Dec. 2025 (¥617 Mil) to Mar. 2026 (¥591 Mil) but then increased from Mar. 2026 (¥591 Mil) to Jun. 2026 (¥597 Mil).

Jinyu Bio-Technology Co's annual Ending Cash Position declined from Dec. 2023 (¥1,053 Mil) to Dec. 2024 (¥814 Mil) and declined from Dec. 2024 (¥814 Mil) to Dec. 2025 (¥617 Mil).

Jinyu Bio-Technology Co Ending Cash Position Related Terms

Jinyu Bio-Technology Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Jinyu Bio-Technology Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jinyu Bio-Technology Co Ending Cash Position Chart

Jinyu Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,182.59 1,266.66 1,052.76 813.92 616.75

Jinyu Bio-Technology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 758.56 857.25 616.75 591.43 597.20
SHSE:600201
60GF Score
Jinyu Bio-Technology Co Ltd SHSE:600201
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jinyu Bio-Technology Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Jinyu Bio-Technology Co's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=813.924+-197.179
=617

Jinyu Bio-Technology Co's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=591.432+5.771
=597

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ¥597 Mil mean?
Jinyu Bio-Technology Co (SHSE:600201) has a Ending Cash Position of ¥597 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Jinyu Bio-Technology Co and its competitors.
Is Jinyu Bio-Technology Co's Ending Cash Position too high?
Jinyu Bio-Technology Co's current Ending Cash Position is ¥597 Mil. Overall, Jinyu Bio-Technology Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's Ending Cash Position compare to VRTX and REGN?
Jinyu Bio-Technology Co's Ending Cash Position of ¥597 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Jinyu Bio-Technology Co and its competitors. Jinyu Bio-Technology Co's current Ending Cash Position is ¥597 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.13, compared to a current price of ¥12.30 — trading 34.7% above its estimated fair value. The current Ending Cash Position is ¥597 Mil. Jinyu Bio-Technology Co's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current Ending Cash Position is ¥597 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?

Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued. The current stock price of ¥12.30 is trading 34.7% above its estimated GF Value™ of ¥9.13. GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.

Key valuation signals for SHSE:600201:

  • Ending Cash Position: ¥597 Mil
  • GF Value™: ¥9.13 vs. price of ¥12.30 (34.7% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jinyu Bio-Technology Co Business Description

Address No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
60GF Score

Get the complete analysis for SHSE:600201

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.30
Price
¥9.13
GF Value